{"id":"NCT01371656","sponsor":"Children's Oncology Group","briefTitle":"Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation","officialTitle":"A Randomized Trial of Levofloxacin to Prevent Bacteremia in Children Being Treated for Acute Leukemia (AL) or Undergoing Hematopoietic Stem Cell Transplantation (HSCT)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-09","primaryCompletion":"2017-06","completion":"2017-06","firstPosted":"2011-06-13","resultsPosted":"2018-06-26","lastUpdate":"2020-12-07"},"enrollment":624,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"SINGLE","primaryPurpose":"SUPPORTIVE_CARE"},"conditions":["Acute Leukemias of Ambiguous Lineage","Bacterial Infection","Diarrhea","Fungal Infection","Musculoskeletal Complications","Neutropenia","Recurrent Childhood Acute Lymphoblastic Leukemia","Recurrent Childhood Acute Myeloid Leukemia","Secondary Acute Myeloid Leukemia","Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies"],"interventions":[{"type":"DRUG","name":"levofloxacin","otherNames":["Levaquin","Quixin"]}],"arms":[{"label":"Arm I (levofloxacin)","type":"EXPERIMENTAL"},{"label":"Arm II (standard of care)","type":"NO_INTERVENTION"}],"summary":"This randomized phase III trial studies how well levofloxacin works in preventing infection in young patients with acute leukemia receiving chemotherapy or undergoing stem cell transplant. Giving antibiotics may be effective in preventing or controlling early infection in patients receiving chemotherapy or undergoing stem cell transplant for acute leukemia. It is not yet known whether levofloxacin is effective in preventing infection.","primaryOutcome":{"measure":"Comparison of the Percentage of Patients Having Bacteremia Incidence Between Levofloxacin vs. No Prophylaxis Arms","timeFrame":"Up to 60 days after enrollment or receiving levofloxacin","effectByArm":[{"arm":"Arm I (Levofloxacin)","deltaMin":21.9,"sd":null},{"arm":"Arm II (Standard of Care)","deltaMin":43.4,"sd":null}],"pValues":[]},"eligibility":{"minAge":"6 Months","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":7},"locations":{"siteCount":84,"countries":["United States","Canada"]},"refs":{"pmids":[],"seeAlso":["https://nctn-data-archive.nci.nih.gov/"]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":306},"commonTop":["Sepsis","Hypokalemia","Alanine aminotransferase increased","Hypotension","Respiratory failure"]}}